Therapeutic methods involving gastrointestinal implants
AssigneeMorphic Medical, Inc.
InventorScott SCHORER
Life of this patent
Estimating the term…
Abstract
The present invention provides combination therapies for treating a metabolic disorder, such as type 2 diabetes, obesity, and related comorbidities (e.g., NASH or NAFLD)) in an individual undergoing treatment with a gastrointestinal implant. The combination therapies described herein include methods for treating an individual with a gastrointestinal implant with a metabolic agent, a bariatric procedure, and/or a microbiota modulator.
Claims20
A method of treating a metabolic disorder in an individual undergoing treatment with a gastrointestinal implant, the method comprising administering an incretin modulator to the individual in an effective amount and for a duration to treat the metabolic disorder, wherein the gastrointestinal implant comprises an anchor and a sleeve.
(canceled)
5-10. (canceled)
12-15. (canceled)
(canceled)
23-47. (canceled)
Dependencies are inferred from the claim text.